- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
The world has pledged within the Sustainable Development Goals to end the AIDS epidemic as a public health threat by 2030. Such an extraordinary achievement will require an extraordinary and urgent effort—fully funding and front-loading investment in comprehensive HIV responses and intensifying the focus on the populations and locations in greatest need. The UNAIDS 2016–2021 Strategy elaborates this Fast-Track approach. Adopted by the UNAIDS Programme Coordinating Board in October 2015, the Strategy contains HIV service coverage targets that need to be achieved by 2020 to establish the momentum necessary to overcome one of the largest public health threats in human history by 2030.
The cost of inaction is staggering. Failure to Fast-Track would translate to an additional 17.6 million HIV infections globally and an additional 10.8 million AIDS-related deaths globally between 2016 and 2030.
This new guide from the USAID- and PEPFAR-funded Health Policy Project is a flexible tool for assessing the readiness and ability of country stakeholders (including government, development partners, and civil society) to sustain HIV epidemic control among key populations when donors transition to different levels and types of funding.
This report provides an overview of institutional funding for LGBTI issues around the world. It captures data on funding from foundations, intermediaries, corporations, government agencies, and multilateral agencies, but does not include individual donors. It covers funding provided by these institutions in calendar years 2013 and 2014 for LGBTI-focused organizations and for projects that specifically focus on LGBTI communities.
Under the leadership of the Government of Bangladesh (GOB), the National AIDS/STD Programme (NASP) and UNAIDS in liaison with civil society stakeholders started the process of the Investment Case for Bangladesh to enhance the mobilization of resources (domestic and external donor) to end AIDS BY 2030 through Fast-Track strategies. The Investment Case makes an effort to outline how to maximize efficient use of resources, based on current evidence, by re-visiting the strategic directions in prevention efforts to fast track and intensify. The process included several review sessions facilitated by the Ministry of Health and Family Welfare, engaging researchers, civil society and government.
Over the past three decades, historic progress has transformed HIV from a deadly disease to a chronic condition. Critical milestones have been reached towards universal access: more than 17 million people globally are receiving HIV treatment, and the world is on track to eliminate mother to child transmission of HIV.
Still, more than 2 million people are newly infected with HIV annually. Last year alone 1.1 million people needlessly lost their lives and HIV remains one of the leading causes of death among children under five years old, adolescents and women of reproductive age. Since the beginning of the epidemic, more than 70 million people have died due to AIDS. Despite the extraordinary progress, HIV remains a serious challenge for global health and development goals.
This report, Financing the Response to AIDS in Low- and Middle-Income Countries: International Assistance from Donor Governments in 2015, tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Donor government funding to support HIV efforts in low- and middle-income countries fell for the first time in five years in 2015, decreasing from US$8.6 billion in 2014 to US$7.5 billion.
The new report, produced as a partnership between the Kaiser Family Foundation and UNAIDS, provides the latest data available on donor funding disbursements based on data provided by governments. It includes their bilateral assistance to low- and middle-income countries and contributions to the Global Fund as well as UNITAID.
Keywords: HIV, funding, governments, donors, resources
In the context of discussions on health spending targets, this paper analyses not only how much countries spend on health, but how they performance in terms of universal health coverage (UHC) relative to that spending. The paper highlights the limited use of spending targets to inform country policy dialogue and decision making.
Keywords: universal health coverage (UHC), health spending, expenditure targets
This report is the outcome of a comparative analysis of seven national investment cases from the region, and highlights key findings and recommendations for further action. The findings from this report and the Regional Expert Consultation on Developing Evidence-Based National HIV Investment Cases and Sustainability Plans held in December 2015 are expected to contribute to the knowledge base on how ESCAP Member States have developed national investment cases (NICs), and identify examples of best practice. The analysis was based primarily on a desk review of the investment cases of Bangladesh, Indonesia, Myanmar, Nepal (Investment Plan), the Philippines, Thailand and Viet Nam, with additional input from in-country respondents and from the Regional Expert Consultation.
Keywords: HIV, epidemic, spending, investment, cases, advocacy
The global commitment to ending the AIDS epidemic represents an unparalleled opportunity to end one of the most devastating modern-day health challenges. Over the past three decades, historic progress has transformed the AIDS response. More than 18 million people globally are receiving life-saving HIV treatment, and the world is on track to eliminate mother-to-child transmission of HIV. However, more than 2 million people are newly infected with HIV annually and, in 2015, more than a million people died from HIV-related causes. Strategic partnerships such as that of UNAIDS and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) are vital if we are to Fast-Track the AIDS response to end AIDS as a public health threat by 2030.